// App-Quantinova.ai

: Using individual pharmacokinetic parameters on octocog alfa to predict individual pharmacokinetic parameters on efmoroctocog alfa in persons with hemophilia A

Researchers

Presenter

  • J. Yu

Principal Investigators

  • P. Chelle

  • A. Iorio

  • A. Edginton

Medical Centers

  • School of Pharmacy, University of Waterloo, Waterloo, ON, Canada

  • Health Research Methods, Evidence, and Impact

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • Antihemophilic factor recombinant

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bayer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved